Yu-Sheng Lin1,2,3, Pi-Hua Liu4,3, Pao-Hsien Chu1,2,5. 1. Department of Cardiology, Chang Gung Memorial Hospital and Chang Gung University. 2. Healthcare Center, Chang Gung Memorial Hospital and Chang Gung University, Taipei. 3. Department of Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan, Taiwan. 4. Clinical Informatics and Medical Statistics Research Center, College of Medicine, Chang Gung University, Taoyuan. 5. Heart Failure Center, Chang Gung Memorial Hospital and Chang Gung University, Taipei.
Abstract
BACKGROUND: Obstructive sleep apnea (OSA) is common in heart failure (HF) patients and exacerbates the outcome of this chronic disease. However, the frequency of HF arising from OSA is varied, with little supporting literature. Here, we aimed to clarify the incidence risk of HF and major adverse cardiac events (MACEs) in OSA patients from the Taiwan large database. METHODS AND RESULTS: From 2000-2010, a total of 2699 newly diagnosed OSA patients after polysomnographic study and 13,490 non-OSA patients utilizing 1:5 matching was enrolled and followed to 2011. Compared to the non-OSA cohort, the OSA cohort increased its MACEs incidence 1.95-fold high and HF incidence reached its highest level, up to 2.75-fold [confidential interval (CI): 1.76-4.29; p value < 0.001]. The most common MACE event was stroke, with a 1.75-fold higher risk in the OSA cohort (CI: 1.37-2.20; p value < 0.001). Although the trend is similar, the OSA cohort showed an increased incidence of atrial fibrillation of approximately 1.63-fold high, (CI: 0.78-3.40; p value: 0.193) and 1.44 high, (CI: 0.74-2.79; p value: 0.287) in myocardial infarction. Between genders, HF risk is considerably higher in female OSA cohort than in corresponding males [female: 6.13 (2.68-14.00), p value < 0.01; male: 1.95 (1.11-3.43), p value = 0.020]. CONCLUSIONS: OSA patients have nearly triple the HF incidence risk than the non-OSA population, particularly in female OSA patients.
BACKGROUND: Obstructive sleep apnea (OSA) is common in heart failure (HF) patients and exacerbates the outcome of this chronic disease. However, the frequency of HF arising from OSA is varied, with little supporting literature. Here, we aimed to clarify the incidence risk of HF and major adverse cardiac events (MACEs) in OSA patients from the Taiwan large database. METHODS AND RESULTS: From 2000-2010, a total of 2699 newly diagnosed OSA patients after polysomnographic study and 13,490 non-OSA patients utilizing 1:5 matching was enrolled and followed to 2011. Compared to the non-OSA cohort, the OSA cohort increased its MACEs incidence 1.95-fold high and HF incidence reached its highest level, up to 2.75-fold [confidential interval (CI): 1.76-4.29; p value < 0.001]. The most common MACE event was stroke, with a 1.75-fold higher risk in the OSA cohort (CI: 1.37-2.20; p value < 0.001). Although the trend is similar, the OSA cohort showed an increased incidence of atrial fibrillation of approximately 1.63-fold high, (CI: 0.78-3.40; p value: 0.193) and 1.44 high, (CI: 0.74-2.79; p value: 0.287) in myocardial infarction. Between genders, HF risk is considerably higher in female OSA cohort than in corresponding males [female: 6.13 (2.68-14.00), p value < 0.01; male: 1.95 (1.11-3.43), p value = 0.020]. CONCLUSIONS: OSA patients have nearly triple the HF incidence risk than the non-OSA population, particularly in female OSA patients.
Entities:
Keywords:
Heart failure; Major adverse cardiovascular events; Obstructive sleep apnea
Authors: Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi Journal: Am J Respir Crit Care Med Date: 2010-03-25 Impact factor: 21.405
Authors: Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers Journal: J Am Coll Cardiol Date: 2007-01-22 Impact factor: 24.094
Authors: Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; T Douglas Bradley Journal: Am J Respir Crit Care Med Date: 2005-09-01 Impact factor: 21.405
Authors: Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley Journal: J Am Coll Cardiol Date: 2007-04-02 Impact factor: 24.094
Authors: Daniel I McIsaac; Andrea Gershon; Duminda Wijeysundera; Gregory L Bryson; Neal Badner; Carl van Walraven Journal: Anesthesiology Date: 2015-08 Impact factor: 7.892
Authors: John T Parissis; Lilian Mantziari; Nikolaos Kaldoglou; Ignatios Ikonomidis; Maria Nikolaou; Alexandre Mebazaa; Johann Altenberger; Juan Delgado; Fabio Vilas-Boas; Ioannis Paraskevaidis; Maria Anastasiou-Nana; Ferenc Follath Journal: Int J Cardiol Date: 2012-10-04 Impact factor: 4.164
Authors: Christopher A Pumill; Christopher G Bush; Melissa A Greiner; Michael E Hall; Shannon M Dunlay; Adolfo Correa; Lesley H Curtis; Takeki Suzuki; Chantelle Hardy; Chad T Blackshear; Emily C O'Brien; Robert J Mentz Journal: Am Heart J Date: 2019-03-08 Impact factor: 4.749
Authors: Ugur Nadir Karakulak; Sercan Okutucu; Utku Lokman; Ovunc Bilgin; Engin Tutkun; Omer Hinc Yilmaz; Ali Oto Journal: Acta Cardiol Sin Date: 2019-01 Impact factor: 2.672